Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2023 Feb 1.
Published in final edited form as: J Pain Symptom Manage. 2021 Aug 8;63(2):301–310. doi: 10.1016/j.jpainsymman.2021.07.032

Completion of Patient-Reported Outcome Questionnaires among Older Adults with Advanced Cancer

Marie A Flannery 1, Supriya Mohile 2, Eva Culakova 2, Sally Norton 1, Charles Kamen 2, J Nicholas Dionne-Odom 3, Grace DiGiovanni 2, Lorraine Griggs 4, Thomas Bradley 5, Judith O Hopkins 6, Jane Jijun Liu 7, Kah Poh Loh 2
PMCID: PMC8816807  NIHMSID: NIHMS1739919  PMID: 34371137

Abstract

Context:

Systematic collection of patient-reported outcomes (PROs) reduces symptom burden and improves quality of life. The ability of older adults to complete PROs, however, has not been thoroughly studied.

Objectives:

To determine whether older adults with advanced cancer received assistance completing PROs, the nature of the assistance, the factors associated with receiving assistance, and how the prevalence of assistance changed over time.

Methods:

Data were obtained from a multisite cluster randomized controlled study of geriatric assessment (Clinicaltrials.gov: NCT02107443). Adults ≥70 years with advanced cancer completed multiple PROs at 4 time points (enrollment, 6 weeks, 3 months, 6 months). Factors associated with receipt of assistance were assessed with bivariate and multivariate analyses.

Results:

The study included 541 adults (range 70–96 years, 49% female, mixed incurable cancer diagnoses). Twenty-eight percent (153/541) received assistance completing PROs. Of these, 42% received assistance from caregivers, 37% from research staff, and 15% from both. Factors associated with receiving assistance included older age [Adjusted Odds Ratio (AOR) 3.71, 95% Confidence Interval (CI) 1.03–13.38], lower education level (3.92, 2.11–7.29), impaired cognition (1.90, 1.23–2.93), impaired functional status (2.16, 1.33–3.52), and impaired hearing (1.38, 1.05–1.80). Eighty percent of individuals who received assistance were identified at study initiation. Receiving assistance decreased over time from 28% to 18%, partially due to drop-outs.

Conclusion:

Over a quarter of older adults with advanced cancer in this study received assistance completing PROs. Completing PROs is a key aspect of many clinical programs and cancer trials; assistance in completing PROs should be offered and provided.

Keywords: Older adult, advanced cancer, questionnaire completion, patient reported outcomes, geriatric oncology, geriatric assessment

Introduction 3485/3500

The importance of patients’ voices in the provision of person-centered care and evaluation of new treatments is increasingly recognized in oncology (1, 2). Patient voices are most often conveyed through the use of patient-reported outcomes (PROs). PROs are data provided by patients, in contrast to data generated by clinicians or from laboratory and radiological studies. Studies have demonstrated that collection and monitoring of PROs [i.e., symptoms, quality of life (QoL), and performance scales] with subsequent feedback provided to oncology clinicians improves outcomes. These outcomes include QoL, symptoms, patient-provider communication, satisfaction with care, and survival (39). Although the importance of incorporating PROs as a standard of care in oncology (5, 7) is clear, collection of PROs in clinical practice remains variable and inconsistent. User’s Guides to PROs implementation provide strategies to address clinician- and system- related barriers (e.g., limited provider buy-in, poor integration with electronic medical records, and work flow burden) (7, 1013). However, these guidelines do not address the specific barriers that older adults encounter in the completion of PROs.

Older adults comprise the majority of individuals diagnosed with and dying from cancer and are a population projected to increase (1416). Practice guidelines from the American Society of Clinical Oncology (ASCO) [for Geriatric Assessment (GA) (2) and palliative care (17)] and the International Society of Geriatric Oncology (SIOG) [guidelines for routine monitoring of symptoms and QoL in the older adult cancer population (2, 18, 19)] recommend routine completion of PROs by older adults with cancer (20). Concerns about possible burdens associated with completion of PROs discourage acceptance of these guidelines, and implementation of guideline-based care requires knowledge of the resources required for older adults to complete PROs.

While studies have shown that collection of PROs is feasible, older adults have often been underrepresented in study populations (2123). Research staff have reported that completion of PROs was more challenging for older and ill individuals with cancer (22). Although data from GA trials suggest that many older adults with cancer can complete PROs (2427), they also indicate that a subset of older adults requires assistance. Ironically, older adults with advanced cancer may be a group which could benefit most from a focus on improving symptoms and promoting QoL (17).

Two juxtaposing threats may limit the ability of older adults to benefit from implementation of PRO-based initiatives. First, they may not be approached to participate because of concerns about potential burden or inability to complete PROs. Second, older adults may be asked to complete PROs but not offered the assistance which may be required because of aging-related needs (e.g. visual impairment). Potential disparities in care can be further exacerbated if older adults cannot report PROs independently.

To better understand the receipt of assistance for PRO completion among older adults with cancer, a secondary analysis of data from a large multi-site cluster randomized clinical trial that tested the efficacy of GA guided intervention was conducted. In this trial, data on PRO completion and receipt of assistance with PRO completion were collected from participants. The study protocol allowed for research staff and caregivers to provide assistance to patients completing PROs. The objective of this analysis was to determine whether older adults with advanced cancer received assistance with completion of PROs, what kind of assistance was provided, and what factors were associated with receiving assistance with PRO completion. We also examined the trajectory of receiving assistance with PRO completion over 6 months and the relationship of receiving assistance with drop-out.

Methods

Study Design, Setting, and Participants

This was a secondary analysis of data from a nationwide GA cluster randomized controlled study conducted within the University of Rochester Cancer Center National Cancer Institute Community Oncology Research Program (clinicaltrials.gov: NCT02107443). Participants were enrolled from 31 community oncology settings across the United States. The institutional review boards at the University of Rochester and at each participating site approved the study, and all patients provided informed consent.

The primary study aim, which was previously reported (27), was to examine the effects of a GA intervention on discussions of aging-related concerns and patient and caregiver satisfaction with care (28). Eligibility criteria included age ≥70 years old, diagnosis of an advanced solid tumor malignancy or lymphoma (stage IV cancer or stage III if cure is not possible or anticipated), considering or receiving any kind of cancer treatment, have planned visits with oncology for at least 3 months, and have impairment in at least one GA domain (e.g., functional status, cognition) other than polypharmacy (Supplementary Table 1).

All patients in the study received a GA at baseline, which included eight domains (e.g. function status, nutritional status); each domain was scored as impaired or not impaired according to pre-established cut points (28). The intervention included a tailored list of recommendations which were given to the oncologist immediately prior to a clinic visit for discussion with the patient. For example, an individual with impaired physical status would receive recommendations for fall prevention and a referral to a physical therapist. In the usual care arm, oncologists were notified only of impaired scores in depression or cognition. As part of the study, patients were asked if they received assistance with completion of self-report measures, which is the focus of this analysis.

Measures

Patients completed study questionnaires at baseline and at 4–6 weeks, 3 months, and 6 months. At each time point, participants were asked to complete 12–22 pages of questionnaires, with a median of 4 questions per page (range 1–16) which included standardized scales. PRO questionnaires were completed on paper using standardized TeleForms (scanable forms for data capture), which were formatted in Arial 12-point font. Examples of PROs collected during the trial included a symptom scale (MD Anderson Symptom Inventory), a QoL measure (Functional Assessment of Cancer Therapy- General), and multiple functional measures (Activities of Daily Living, Instrumental Activities of Daily Living). These measures have been described in prior reports (29). A complete listing of PROs is provided (Supplemental Table 2).

Dependent Variable – receiving assistance with PROs completion

Included was a survey completion questionnaire that asked a) where the participant completed the questionnaires (home, doctor’s office, home and doctor’s office, or other location) and b) if someone assisted them in completing the questionnaires (yes or no). If participants answered yes to receiving assistance, they were asked c) who provided assistance completing the questionnaires (caregiver, research staff, caregiver and research staff, or other), and d) how the person(s) assisted (read the questions, wrote the answers, answered the questions for the patient, or assisted in some other way).

Covariates

Demographic, clinical, and aging-related factors that might be associated with receiving assistance with PRO completion were assessed. These factors included patient-reported demographics [age (70–79 vs. 80–89 vs. >90 years), gender (female vs. male), race (white vs. other), education (some college or above vs. high school graduate vs. less than high school), living situation (lives alone vs. not), marital status (partnered vs. not partnered)], Karnofsky Performance Status (KPS; ≤60 vs. 70. vs. 80 vs. 90 vs. 100), and cancer type (collected by study staff from the medical record; categorized into gastrointestinal vs. lung vs. other based on frequencies and clinical relevance). All aging-related factors were assessed using GA [i.e., comorbidity, vision (poor vs. fair vs. good vs. excellent), hearing (poor vs. fair vs. good vs. excellent), polypharmacy, physical performance, functional status, psychological health, nutritional status, cognition, and social support; see Supplemental Table 1 for a complete list of all measures included in the GA]. GA measures were scored following pre-established cut points as impaired vs. not impaired (29). For covariates for which many categories of data were collected, some categories were combined based on clinical relevance specific to older adults with advanced cancer, in order to achieve fewer groups with larger sample sizes.

Statistical Analyses

Descriptive statistics were used to summarize findings. Bivariate analyses (Chi-Square test) were used to describe associations of patients’ demographic, disease, and aging-related factors with receiving assistance with PRO completion at baseline. Logistic regression analysis was used to evaluate the multivariate relationship. The pool of independent covariates was predefined based on clinical relevance (all candidate covariates are listed in Table 1). The final model was selected using a stepwise selection process (SAS: proc logistic with stepwise option) with a p value of 0.15 chosen for entry and elimination from the model. A p value of 0.15 was chosen to balance between reducing the number of parameters and model fit. P=0.15 is close to the critical level (0.157) for which a stepwise procedure is asymptotically equivalent to select the model covariates based on Akaike Information Criterion (AIC)(30, 31). Covariates in the final model were examined for collinearity using variance inflation factor (VIF). No serious collinearity was detected (all VIF<1.3, where VIF=3 is a threshold for concern). Interactions of age and education variables with aging related conditions and performance status were examined (p>0.05 for all).

Table 1.

Demographics and clinical characteristics at baseline: Bivariate analysis for group differences

Individuals who did not receive assistance with PROs Individuals who received assistance with PROs % Received assistance P valuea
N=388 N=153
Demographic and clinical characteristics N (%) N (%) %
Age b
 70–79 298 (76.8) 103 (67.8) 25.7 0.017
 80–89 85 (21.9) 42 (27.6) 33.1
 90–96 5 (1.3) 7 (4.6) 58.3
Gender b
 Female 192 (49.5) 84 (55.3) 30.4 0.227
 Male 196 (50.5) 68 (44.7) 25.8
Non-Hispanic white b
 No 36 (9.3) 22 (14.5) 37.9 0.080
 Yes 352 (90.7) 130 (85.5) 27.0
Education b
 <High school 31 (8.0) 35 (23.0) 53.0 <0.001
 High school graduate 132 (34.0) 63 (41.4) 32.3
>Some college or higher 225 (58.0) 54 (35.5) 19.4
Living arrangements b
 Lives with others 304 (78.4) 124 (81.6) 29.0 0.405
 Lives alone 84 (21.6) 28 (18.4) 25.0
Marital status
 Married/partnered 138 (35.6) 54 (35.3) 28.1 0.952
 Not partnered 250 (64.4) 99 (64.7) 28.4
Karnofsky performance status c
 ≤60 27 (7.0) 32 (21.1) 54.2 <0.001
 70 38 (9.8) 16 (10.5) 29.6
 80 141 (36.4) 57 (37.5) 28.8
 90 120 (31.0) 29 (19.1) 19.5
 100 61 (15.8) 18 (11.8) 22.8
Cancer type
Gastrointestinal 104 (26.8) 35(22.9) 25.2 0.408
Lung 103 (26.5) 37 (24.2) 26.4
Other 181 (46.6) 81 (52.9) 30.9
Aging-related factors
Vision
 Poor 9 (2.3) 8 (5.2) 47.1 0.005
 Fair 55 (14.2) 36 (23.5) 39.6
 Good 241 (62.1) 89 (58.2) 27
 Excellent 83 (21.4) 20 (13.1) 19.4
Hearing
 Totally deaf 0 (0) 1 (0.7) 100 0.001
 Poor 15 (3.9) 17 (11.1) 53.1
 Fair 90 (23.2) 43 (28.1) 32.3
 Good 213 (54.9) 77 (50.3) 26.6
 Excellent 70 (18) 15 (9.8) 17.6
Impaired polypharmacy
No 73 (18.8) 15 (9.8) 17.0 0.011
Yes 315 (81.2) 138 (90.2) 30.5
Impaired comorbidity
 No 151 (38.9) 45 (29.4) 23.0 0.038
 Yes 237 (61.1) 108 (70.6) 31.3
Impaired social support
 No 266 (68.6) 119 (77.8) 30.9 0.033
 Yes 122 (31.4) 34 (22.2) 21.8
Impaired cognition
 No 284 (73.2) 77 (50.3) 21.3 <0.001
 Yes 104 (26.8) 76 (49.7) 42.2
Impaired nutritional status
 No 163 (42.0) 52 (34.0) 24.2 0.086
 Yes 225 (58.0) 101 (66.0) 31.0
Impaired physical performance
 No 27 (7.0) 7 (4.6) 20.6 0.304
 Yes 361 (93) 146 (95.4) 28.8
Impaired functional status
 No 186 (47.9) 36 (23.5) 16.2 <0.001
 Yes 202 (52.1) 117 (76.5) 36.7
Impaired psychologic status
 No 310 (79.9) 95 (62.1) 23.5 <0.001
 Yes 78 (20.1) 58 (37.9) 42.6
a

Differences assessed with Chi-Square Test

b

1 patients had missing data

c

2 patients had missing data

Patient Reported Outcomes (PROs)

To examine longitudinal aspects of receiving assistance, the data were visualized graphically using Sankey flow diagrams (constructed by Python software). Sankey was selected for visualization because it demonstrated the flow of patients from one assessment to the next assessment. Patients were categorized as receiving assistance (help) vs. not receiving assistance (no help) with PROs completion. The figure incorporates drop out (collection of PROs was discontinued). Association of receiving assistance at baseline with the timing of drop out was evaluated by the Kruskal-Wallis Test. Statistical analyses were conducted using the SAS software package (version 9.4).

Results

The parent study included 541 older patients [mixed cancer diagnosis (26% gastrointestinal, 26% lung cancer), all had advanced incurable cancer]. Mean age was 77 years [standard deviation (SD) 5.2, range 70–96], 49% were female, 89% were white, and 48% had a high school or less education. Individuals reported a mean of 4.5 (SD 1.5; range 1–8) impaired GA domains (Table 1). Over the six months of the study, 35% of patients withdrew, most commonly due to death or hospitalization/hospice. Other detailed participant characteristics have been previously reported (29, 32).

At study entry, 62% (337/541) of patients reported completing the surveys at home, 29% (155/541) at the doctor’s office, 4% (19/541) at both places, and 6% (30/541) at another location. Seventy-two percent (388/541) completed the questionnaires independently, with 28% (153/541) receiving assistance from someone at baseline screening. All PROs were completed with very minimal (<1%) missed items.

Of the 153 patients who reported receiving assistance at screening, 42% (64/153) received assistance from their caregiver, 37% (57/153) from research staff, 15% (23/153) from both, and 6% (9/153) from others (Figure 1a). Most of the assistance was provided in the form of reading questions or writing down answers for the patient (75%; 114/153): specifically, 44% (68/153) both reading questions and writing answers, 22% (33/153) reading questions only, and 8% (13/153) writing answers only. An additional 18% (27/153) reported receiving assistance in another way (e.g., clarification), and 8% (12/153) reported that the questions were answered for them (Figure 1b). On the free text box, some participants commented about other assistance received and noted that assistance was in the form of explanation or clarification of a question, and they also stated that assistance was received for only one or a few questions and not for all.

Figure 1a. Who provided assistance in completing PROs.

Figure 1a

Figure 1b. Types of assistance provided for completing PROs.

Figure 1b

On bivariate analyses, patients who were older, those with lower educational levels, lower KPS, or impairment in vision, hearing, polypharmacy, comorbidity, functional status, psychological status, and cognition were more likely to report receiving assistance completing questionnaires (see Table 1). Compared to those with impairment in social support, those without impairment were more likely to report receiving assistance completing questionnaires (31 vs. 22%, p=0.03).

On multivariate analysis (Table 2), factors independently associated with receiving assistance included older age [90–96 years vs. 70–79 years, Adjusted Odds Ratio (AOR) 3.71, 95% Confidence Interval (CI) 1.03–13.38], lower educational level (high school graduate vs. some college or higher, AOR 1.80, 95% CI 1.14–2.84; less than high school vs. some college or higher, AOR 3.92, 95% CI 2.11–7.29), impaired cognition (AOR 1.90, 95% CI 1.23–2.93), impaired functional status (AOR 2.16, 95% CI 1.33–3.52), and impaired hearing (AOR 1.38, 95% CI 1.05–1.80). In contrast, patients who had impaired social support were less likely to report receiving assistance (AOR 0.55, 95% CI 0.34–0.90).

Table 2.

Multivariate logistic regression analysis: Associations with receiving assistance completing Patient Reported Outcomes

Variable Category Odds ratio 95% CI P-value
Age 80–89 vs 70–79 1.25 (0.76–2.04) 0.377
90–96 vs 70–79 3.71 (1.03–13.38) 0.045
Education <HS vs some college or higher 3.92 (2.11–7.29) <.0001
HS graduate vs some college or higher 1.80 (1.14–2.84) 0.011
Karnofsky performance status Excellent to poor 1.02 (1–1.04) 0.082
Hearing Excellent to poor 1.38 (1.05–1.80) 0.020
Medical social support Impaired 0.55 (0.34–0.90) 0.017
Cognition Impaired 1.90 (1.23–2.93) 0.004
Functional status Impaired 2.16 (1.33–3.52) 0.002
Psychologic status Impaired 1.57 (0.99–2.51) 0.056

Abbreviations: HS = high school, CI =Confidence Interval

C statistics=0.75

CI Confidence Interval

Longitudinal examination revealed that both the percent and actual number of individuals reporting receiving assistance with PROs completion decreased over time: 28% at baseline (153/541), 22% at 4–6 weeks (104/472), 20% at 3 months (80/409), and 18% at 6 months (62/349). As displayed in the Sankey flow diagram (Figure 2), the pattern of responses over the 6-month course of the study indicates that the majority of individuals who received assistance were identified at study initiation and that this group of individuals was more likely to withdraw from the study than those who did not receive assistance (p=0.03). We further examined this finding by comparing individuals at baseline and at the 4–6 week follow-up time point. Approximately half (52%, 79/153) of the individuals who received assistance at baseline continued to receive assistance at time 2, while 18% (27/153) did not provide data at the second time point (due to drop out), and the remainder (31%, 47/153) no longer received assistance. In contrast, only 24% (25/104) of individuals received assistance at the 4–6 week interval who had not received assistance at baseline.

Figure 2. Sankey flow diagram of receiving assistance completing PROs.

Figure 2

Note: Help is substituted for assistance due to space constraints

Green –did not receive assistance

Red- received assistance

Gray- dropped out of study

Note: The diagram visualizes within-subject flow (change) from one time point to the next time point. The height of the bars corresponds to the number of patients. To read the Sankey, focus on one color. Focusing on red at baseline (the patients who received help), the arc/flow of these patients to assessment time point 2 (4–6 weeks) demonstrates that the majority still needed help (largest red arc), while a smaller group no longer needed help (smaller red arc), and an even smaller group dropped out.

Discussion

Two threats to older adults from benefitting from PROs were outlined in the introduction, and our findings addressed both. First, the risk that potential burden or inability to complete PROs may exclude older adults from being asked to provide PRO data. Second, the failure to offer assistance to older adults to complete PROs may prevent them from full participation - assistance which may be required because of aging-related needs. While we found that 72% of older adults with advanced cancer were able to complete PROs independently, over a quarter of them required assistance. Our study indicates that assistance in completing PROs should be provided to older adults through implementation of strategies and work flow processes. We also found that when provided a choice, more than 60% of older adults chose to complete questionnaires at home, indicating that home completion may be a viable and preferred choice for many older individuals when the option and timing are appropriate for data collection. Caregivers frequently provide assistance to patients in completing PROs. In addition, the type of assistance provided (i.e., reading questions and writing responses) and the characteristics associated with receiving assistance were quantified [e.g. educational level, age, impairments in functional level and psychological status].

Both QoL scales and PROs used in GA (24) can generally be completed by patients independently without assistance (33, 34). Similarly, commonly used symptom scales are reported to be feasible (3537), but specific details on whether assistance is required to complete them is often not provided. In prior studies, the proportion of older adults who required assistance with GA questionnaires has ranged from 8% (38) to 14–24% (39), consistent with our findings. For example, Hurria (27) and colleagues found that 78% of older adults were able to independently complete the PROs in GA (administered electronically), although the participants had a mix of curable and advanced cancers. Results from our study provide evidence that many older adults can independently complete multiple PROs and expand the findings to those with advanced cancer. Whereas past studies have reported on completion of GA questionnaires, symptom scales, or QoL instruments individually, our study included all of these.

We found that 28% of older adults received assistance with PROs. Of these, over half (52%) received assistance from research staff. Patients frequently received assistance from caregivers in this study, and while this did not place resource demands on the research team, it did reveal an under-recognized role of caregivers. In this study, we specifically asked what type of assistance was provided, and the most common form of assistance was reading and/or writing responses for the patient. When assistance was provided, it was rare that questions were answered for the patient, indicating completion by proxy was not a major occurrence. Having self-report measures completed by proxy is known to provide different results from when the patient reports independently (40, 41). Further research is indicated to examine in greater detail the role of caregivers who assist patients in completing PROs.

Several key factors associated with receiving assistance were identified. Consistent with prior research, we found that lower educational levels were associated with receiving assistance (22). Our findings that older adults were more likely to receive assistance is aligned with prior reports that these individuals have more difficulty with completing PRO-CTCAE (Common Terminology Criteria for Adverse Events) (22). Impairment in multiple GA-related factors (i.e., in hearing, cognition, and functional status) were associated with receiving assistance, indicating the utility of GA in identifying or screening at risk individuals. In contrast, patients who had good social support were more likely to receive assistance completing PROs. One possible interpretation for this finding is that individuals with impaired social support did not have a caregiver to ask for assistance and thus completed PROs independently. Social support is a critical and important factor related to QoL outcomes in older adults (42, 43). Shahronki and colleagues (44) noted differences in CTCAE toxicity based on social support in older individuals. Individuals with poor social support were less likely to have documented CTCAE non-hematologic toxicities, supporting the importance of monitoring older adults using PROs.

Many of the individuals who were most likely to receive assistance with PROs were identifiable at study initiation, indicating that up front screening measures can be implemented to identify at risk individuals. It is imperative that there is equitable participation of vulnerable high risk groups such as older adults with advanced cancer in both clinical trials and clinical initiatives. To achieve this, procedures need to be in place to screen for at risk individuals so that assistance for PRO completion can be provided in this population. Our study may serve as a guide to estimate resource and budgetary requirements for clinical initiatives or research studies involving PRO collection from older adults with cancer. It is unsurprising that individuals who received assistance were more likely to drop out of the study because of death, hospital admission, or enrollment in hospice, perhaps indicating that requiring assistance with PRO completion is associated with more complex issues. This group of individuals can often be identified at the first time they are asked to complete; therefore, we recommend addressing by planning to offer assistance. One straightforward approach is to ask all older adults, “Do you need any help with completing these forms?” Another option is to screen for risk factors with GA to identify individuals who may need assistance with PROs. Practical implications include creating questionnaires that are easy to read, with specific font types (serif) and size (16) recommended for older adults. Recommendations and guidance are available from several organizations including the National Institute on Aging (45), the US Department of Health and Human Services Centers for Medicare & Medicaid Services (46), and the Office of Disease Prevention and Health Promotion (47).

A limitation of this study is that receiving assistance in our sample may have been overestimated; anecdotally, several research staff mentioned that they volunteered to assist individuals with PRO completion to expedite the process and to meet study requirements and timeframes. Assistance by research staff may have been provided when it was not required; thus, the percentage may be an overestimation of individuals who actually required assistance. Second, results may only be generalizable to similar patient populations; participants were drawn from multiple community oncology settings, had advanced cancer, and agreed to participate in a study and did not represent a racially diverse population. Paper questionnaires were used rather than electronic or digital capture of information; the percentage receiving assistance may not transfer to electronically completed formats which have been discussed by others (48). However, results of those receiving assistance in our study are similar to those reported for electronic data capture of PROs by other investigators (22, 23, 49). Challenges (e.g., reading questions, clarification of a question) faced by older adults when completing paper-based assessments are also relevant in the context of electronic assessments. While the use of electronic reporting systems to gather PROs is increasing (50) it is likely that paper-based assessments will remain for some older adults. The reasons for this could be due to patient factors (no access to electronic devices/internet) or system issues (variation in information technology support, resources, and infrastructure).

The importance of PROs for the older adult, especially in the context of advanced cancer where QoL outcomes may be prioritized more highly than length of life (20, 51), is well established. In order to advance our understanding of the tolerability of cancer symptoms and treatments in older adults, this information is essential. Our findings indicate that an identifiable group of older adults with advanced cancer will require assistance completing PROs. Individuals are the only source of information on QoL, and their symptom experience and the value of collecting patient-reported data cannot be overestimated(52).

Supplementary Material

1

Key Message:

Over a quarter of older adults with advanced cancer in this study required assistance in completing PROs from staff or family caregivers. Assistance with PROs should be provided to older adults through implementation of strategies and work flow processes.

Acknowledgements

We would like to thank and acknowledge S. Rosenthal for editorial review.

The funding sources had no involvement in study design, analysis, and interpretation of data, writing, or decision to submit for publication. This work was supported by the National Institutes of Health (NIH NCI UG189961, NIH NIA K24 AG056589, NIH NCI K99CA237744, NIH NCI K07CA190529, and NIH/NINR R00NR015903) and the Patient-Centered Outcomes Research Institute (Grant # 4634).

List

Patient –Centered Outcomes Research Institute (Grant # 4634)

NIH NCI UG189961

NIH NIA K-24 AG056589 (Dr. Mohile)

NIH NCI K99CA237744 (Dr. Loh)

NIH/NINR R00NR015903; National Palliative Care Research Center (Dr. Dionne-Odom)

NIH NCI K07 CA190529 (Dr. Kamen)

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Disclosures

COI: Dr. Loh serves as a consultant to Pfizer and Seattle Genetics. Dr. Loh has received honorarium from Pfizer. KPL is supported by the National Cancer Institute (K99CA237744) and Wilmot Research Fellowship Award.

References

  • 1.Gilligan T, Coyle N, Frankel RM, et al. Patient-Clinician Communication: AmericanSociety of Clinical Oncology Consensus Guideline. J Clin Oncol 2017;35:3618–3632. [DOI] [PubMed] [Google Scholar]
  • 2.Mohile SG, Dale W, Somerfield MR, et al. Practical Assessment and Management ofVulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology. J Clin Oncol 2018;36:2326–2347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Basch E, Deal AM, Kris MG, et al. Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial. J Clin Oncol 2016;34:557–65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Kroenke K, Theobald D, Wu J, et al. Effect of telecare management on pain anddepression in patients with cancer: a randomized trial. JAMA : the journal of the American Medical Association 2010;304:163–171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Kotronoulas G, Kearney N, Maguire R, et al. What is the value of the routine use ofpatient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2014;32:1480–1501. [DOI] [PubMed] [Google Scholar]
  • 6.Licqurish SM, Cook OY, Pattuwage LP, et al. Tools to facilitate communication during physician-patient consultations in cancer care: An overview of systematic reviews. CA Cancer J Clin 2019;69:497–520. [DOI] [PubMed] [Google Scholar]
  • 7.Basch E, Barbera L, Kerrigan CL, Velikova G. Implementation of Patient-ReportedOutcomes in Routine Medical Care. Am Soc Clin Oncol Educ Book 2018;38:122–134. [DOI] [PubMed] [Google Scholar]
  • 8.Kerrigan K, Patel SB, Haaland B, et al. Prognostic Significance of Patient-ReportedOutcomes in Cancer. JCO Oncol Pract 2020;16:e313–e323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Basch E, Deal AM, Dueck AC, et al. Overall Survival Results of a Trial AssessingPatient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment. Jama 2017. [DOI] [PMC free article] [PubMed]
  • 10.Chan EK, Edwards TC, Haywood K, Mikles SP, Newton LJQoLR. Implementingpatient-reported outcome measures in clinical practice: a companion guide to the ISOQOL user’s guide 2019;28:621–627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Aaronson N, Choucair A, Elliott T, et al. User’s guide to implementing patient-reported outcomes assessment in clinical practice 2011. [DOI] [PubMed]
  • 12.Snyder C, Wu AJB, MD: Johns Hopkins University. Users’ guide to integratingpatient-reported outcomes in electronic health records 2017.
  • 13.Ali J, Basch E, Baumhauer J, et al. Users’ Guide to Integrating Patient-Reported Outcomes in Electronic Health Records 2017.
  • 14.Berger NA, Savvides P, Koroukian SM, et al. Cancer in the Elderly. Trans Am ClinClimatol Assoc 2006;117:147–156. [PMC free article] [PubMed] [Google Scholar]
  • 15.Tack L, Lefebvre T, Lycke M, et al. Underrepresentation of vulnerable olderpatients with cancer in phase II and III oncology registration trials: A case-control study. J Geriatr Oncol 2020;11:320–326. [DOI] [PubMed] [Google Scholar]
  • 16.Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA. Future of cancerincidence in the United States: burdens upon an aging, changing nation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27:2758–2765. [DOI] [PubMed] [Google Scholar]
  • 17.Stover AM, Basch EM. The Potential Role of Symptom Questionnaires inPalliative and Supportive Cancer Care Delivery. Curr Oncol Rep 2017;19:12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Scotte F, Bossi P, Carola E, et al. Addressing the quality of life needs of olderpatients with cancer: A SIOG consensus paper and practical guide. Ann Oncol 2018. [DOI] [PubMed]
  • 19.Wildiers H, Heeren P, Puts M, et al. International Society of Geriatric Oncologyconsensus on geriatric assessment in older patients with cancer. J Clin Oncol 2014;32:2595–603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Wedding U, Pientka L, Hoffken K. Quality-of-life in elderly patients with cancer: ashort review. Eur J Cancer 2007;43:2203–10. [DOI] [PubMed] [Google Scholar]
  • 21.Dueck AC, Scher HI, Bennett AV, et al. Assessment of Adverse Events From the Patient Perspective in a Phase 3 Metastatic Castration-Resistant Prostate Cancer Clinical Trial. JAMA Oncol 2019. [DOI] [PMC free article] [PubMed]
  • 22.Basch E, Dueck AC, Rogak LJ, et al. Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048. J Clin Oncol 2018:Jco2018788620. [DOI] [PMC free article] [PubMed]
  • 23.Basch E, Dueck AC, Rogak LJ, et al. Feasibility Assessment of Patient Reporting ofSymptomatic Adverse Events in Multicenter Cancer Clinical Trials. JAMA Oncol 2017;3:1043–1050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Magnuson A, Allore H, Cohen HJ, et al. Geriatric assessment with management incancer care: Current evidence and potential mechanisms for future research. J Geriatr Oncol 2016;7:242–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Hamaker ME, Te Molder M, Thielen N, et al. The effect of a geriatric evaluation on treatment decisions and outcome for older cancer patients - A systematic review. J Geriatr Oncol 2018;9:430–440. [DOI] [PubMed] [Google Scholar]
  • 26.Hurria A, Cirrincione CT, Muss HB, et al. Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401. J Clin Oncol 2011;29:1290–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Hurria A, Gupta S, Zauderer M, et al. Developing a cancer-specific geriatric assessment: a feasibility study. Cancer 2005;104:1998–2005. [DOI] [PubMed] [Google Scholar]
  • 28.Mohile SG, Epstein RM, Hurria A, et al. Communication With Older Patients With Cancer Using Geriatric Assessment: A Cluster-Randomized Clinical Trial From the National Cancer Institute Community Oncology Research Program. JAMA Oncol 2019;6:1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Kehoe LA, Xu H, Duberstein P, et al. Quality of Life of Caregivers of Older Patients with Advanced Cancer. J Am Geriatr Soc 2019;67:969–977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Atkinson AC. Likelihood Ratios, Posterior Odds and Information Criteria. Journal of Econometrics 1981;16:15–20. [Google Scholar]
  • 31.Akaike H Citation Classic - a New Look at the Statistical-Model Identification. Current Contents/Engineering Technology & Applied Sciences 1981:22–22.
  • 32.Mohile SG, Epstein RM, Hurria A, et al. Communication With Older Patients With Cancer Using Geriatric Assessment: A Cluster-Randomized Clinical Trial From the National Cancer Institute Community Oncology Research Program. JAMA Oncol 2019:1–9. [DOI] [PMC free article] [PubMed]
  • 33.Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993;11:570–9. [DOI] [PubMed] [Google Scholar]
  • 34.Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365–76. [DOI] [PubMed] [Google Scholar]
  • 35.Cleeland CS, Mendoza TR, Wang XS, et al. Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer 2000;89:1634–46. [DOI] [PubMed] [Google Scholar]
  • 36.Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 1991;7:6–9. [PubMed] [Google Scholar]
  • 37.Chang VT, Hwang SS, Thaler HT, Kasimis BS, Portenoy RK. Memorial Symptom Assessment Scale. Expert review of pharmacoeconomics & outcomes research 2004;4:171–178. [DOI] [PubMed] [Google Scholar]
  • 38.Hurria A, Akiba C, Kim J, et al. Reliability, Validity, and Feasibility of a Computer-Based Geriatric Assessment for Older Adults With Cancer. J Oncol Pract 2016;12:e1025–e1034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Williams GR, Deal AM, Jolly TA, et al. Feasibility of geriatric assessment in community oncology clinics. J Geriatr Oncol 2014;5:245–51. [DOI] [PubMed] [Google Scholar]
  • 40.Hsu T, Loscalzo M, Ramani R, et al. Are Disagreements in Caregiver and Patient Assessment of Patient Health Associated with Increased Caregiver Burden in Caregivers of Older Adults with Cancer? Oncologist 2017;22:1383–1391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Loh KP, Mohile SG, Lund JL, et al. Beliefs About Advanced Cancer Curability in Older Patients, Their Caregivers, and Oncologists. Oncologist 2019;24:e292–e302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Kadambi S, Soto-Perez-de-Celis E, Garg T, et al. Social support for older adults with cancer: Young International Society of Geriatric Oncology review paper. J Geriatr Oncol 2020;11:217–224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Williams GR, Pisu M, Rocque GB, et al. Unmet social support needs among older adults with cancer. Cancer 2019;125:473–481. [DOI] [PubMed] [Google Scholar]
  • 44.Shahrokni A, Sun CL, Tew WP, et al. The association between social support and chemotherapy-related toxicity in older patients with cancer. J Geriatr Oncol 2020;11:274–279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.National Institute on Aging. Making your printed health materials senior friendly 2007. Available from: http://memoryworks.org/PUBS/NIA/Making%20Your%20Printed%20Health%20Materials%20Senior%20Friendly.pdf.
  • 46.Centers for Medicare Medicaid Services. Toolkit for making written material clear and effective 2020. Available from: https://www.cms.gov/Outreach-and-Education/Outreach/WrittenMaterialsToolkit.
  • 47.Office of Disease Prevention and Health Promotion. Health Literacy Online, Display content clearly on the page 2016. Available from: https://health.gov/healthliteracyonline/display/section-3-3/.
  • 48.Loh KP, McHugh C, Mohile SG, et al. Using Information Technology in the Assessment and Monitoring of Geriatric Oncology Patients. Curr Oncol Rep 2018;20:25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Basch E, Pugh SL, Dueck AC, et al. Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial. Int J Radiat Oncol Biol Phys 2017;98:409–418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.LeBlanc TW, Abernethy AP. Patient-reported outcomes in cancer care - hearing the patient voice at greater volume. Nat Rev Clin Oncol 2017;14:763–772. [DOI] [PubMed] [Google Scholar]
  • 51.Loh KP, Mohile SG, Epstein RM, et al. Willingness to bear adversity and beliefs about the curability of advanced cancer in older adults. Cancer 2019;125:2506–2513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Basch E, Campbell A, Globe D, et al. Capturing symptomatic adverse events from the patients’ perspective: the potential role of the National Cancer Institute’s PROCTCAE measurement system 2015.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

RESOURCES